Loading organizations...
Loading organizations...
Pioneering treatments for neurodegenerative diseases via mitochondrial func
Mitoconix Bio has raised $20.0M across 1 funding round.
Mitoconix Bio has raised $20.0M in total across 1 funding round.
Mitoconix Bio has raised $20.0M in total across 1 funding round.
Mitoconix Bio's investors include Taro Inaba, Jonathan Tobin, Dementia Discovery Fund, OrbiMed, RMGP Bio-Pharma.
Mitoconix Bio has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in June 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 28, 2017 | $20.0M Series A | Taro Inaba | Jonathan Tobin, Dementia Discovery Fund, OrbiMed, RMGP Bio-Pharma |